As COVID-19 has infected more than 1 million people around the world — and more than 2,500 Wisconsin residents — since late December 2019, everything from nose-and-throat swabs to the chemical substances, or reagents, …
Press Release
New Canine Study Investigates Cancers and Exposure to Environmental Chemicals
Posted onCertain dogs may be more susceptible than others to developing environmentally associated cancers. Morris Animal Foundation-funded researchers at the University of Wisconsin-Madison School of Veterinary Medicine are studying how exposure to common environmental chemicals, like …
UW–Madison, Flugen, Bharat Biotech to Develop Coroflu, a Coronavirus Vaccine
Posted onAn international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu. CoroFlu will build …
Growth Continues for Veterinary Clinic Supporting Homeless and Low-income Pet Owners
Posted onFor so many of us, a home isn’t a home without the love of a pet. So to be asked to sacrifice one for the other — keep your housing but lose your pet, or keep …
UW–Madison Researchers Lead Efforts to Understand, Thwart New Coronavirus
Posted onBack in 2016, when Zika virus first began to cause infections in the Americas, University of Wisconsin-Madison researchers pulled together a coalition of scientists to study the virus and openly share their data for others. …
‘Lucky Dog’ Scout and UW School of Veterinary Medicine Star in WeatherTech Super Bowl Commercial
Posted onWhen clinicians at the University of Wisconsin School of Veterinary Medicine began caring for Scout in July 2019, they had no idea they would soon inspire, and appear in, a Super Bowl commercial. But they …
Flashing Lights May Provide Vital First Test of MS Drug Success
Posted onMeasuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to researchers at the University of Wisconsin–Madison, …
Clinical Trial for Ebola Vaccine Developed at UW–Madison Underway in Japan
Posted onAs of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of …
New Flu Drug Drives Drug Resistance in Influenza Viruses
Posted onBy Kelly April Tyrrell On January 31, 2019, an 11-year old boy in Japan went to a medical clinic with a fever. The providers there diagnosed him with influenza, a strain called H3N2, and sent …
Common Chemical Linked to Rare Birth Defect in Mice
Posted on
A chemical commonly used in consumer and agricultural products to boost the effectiveness of insecticides has been linked to a rare birth defect in mice. The chemical, piperonyl butoxide or PBO for short, is widely used as a “synergist” in household and agricultural insecticides to make the toxic effects of the insecticide longer lasting and to reduce the amount of actual insecticide in a product.
Despite its widespread and growing use, as well as its ubiquity in the environment, the chemical has been little studied. Now, a team led by Robert Lipinski, a professor of comparative biosciences in the University of Wisconsin–Madison’s School of Veterinary Medicine, reports that PBO interferes with the critical signaling pathway dubbed by scientists as sonic hedgehog, resulting in stunted forebrain development and signature facial abnormalities. The study is published this week (Oct. 23, 2019) in the journal Environmental Health Perspectives.